Salim Haffar, PCI Pharma CEO

PCI fur­ther ex­pands in­to New Eng­land with fill-fin­ish up­grade in New Hamp­shire

A Philadel­phia-based CD­MO will drop $100 mil­lion in­to its asep­tic liq­uid fill-fin­ish and ster­ile lyophiliza­tion tech­nol­o­gy at its re­cent­ly-ac­quired Bed­ford, NH …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA